BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16680736)

  • 1. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia.
    Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y
    Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid-hormone-related peptide in hematologic malignancies.
    Kremer R; Shustik C; Tabak T; Papavasiliou V; Goltzman D
    Am J Med; 1996 Apr; 100(4):406-11. PubMed ID: 8610726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.
    Schöttker B; Heinz W; Weissinger F; Sözener K; Eck M; Seufert J
    Haematologica; 2006 Dec; 91(12 Suppl):ECR45. PubMed ID: 17194651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute lymphocytic leukemia in adolescence with multiple osteolytic lesions and hypercalcemia mediated by lymphoblast-producing parathyroid hormone-related peptide: a case report and review of the literature.
    Shimonodan H; Nagayama J; Nagatoshi Y; Hatanaka M; Takada A; Iguchi H; Oda Y; Okamura J
    Pediatr Blood Cancer; 2005 Sep; 45(3):333-9. PubMed ID: 15700250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTHrP-independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19-negative precursor B acute lymphoblastic leukemia.
    Niizuma H; Fujii K; Sato A; Fujiwara I; Takeyama J; Imaizumi M
    Pediatr Blood Cancer; 2007 Dec; 49(7):990-3. PubMed ID: 16496289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Peripheral blood involvement accompanied with hypercalcemia in the malignant lymphoma of iliac bone].
    Yoshida A; Ueda T; Tanaka Y; Imura S; Konishi F; Uchida M; Kita K; Nakamura T
    Rinsho Ketsueki; 1991 Apr; 32(4):404-8. PubMed ID: 2067086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma].
    Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypercalcemia associated with parathyroid hormone-related protein(PTHrP)in a patient with diffuse large- type B-cell lymphoma(DLBCL)].
    Hong H; Hayashi T; Hagiwara K; Sugiyama H; Ando K; Kim S; Hino M
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1881-4. PubMed ID: 22083203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-Hodgkin's lymphoma associated with hypercalcemia, multiple osteolytic lesions and diabetes insipidus].
    Pereira J; Grebe G; Lira P
    Rev Med Chil; 1984 Jul; 112(7):689-92. PubMed ID: 6515180
    [No Abstract]   [Full Text] [Related]  

  • 10. Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: the first case reported in the literature and review of the literature.
    Oumeish OY; Oumeish I; Tarawneh M; Salman T; Sharaiha A
    Int J Dermatol; 2006 Mar; 45(3):306-10. PubMed ID: 16533236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay of parathyroid hormone-related peptide (PTHrP), renal insufficiency and bulky disease in the pathogenesis of hypercalcemia in Hodgkin's lymphoma (HL).
    Chevalier N; Udi J; Sigler M; Wolf ME; Heinz J; Schmitt-Graeff A; Seufert J; Wäsch R; Engelhardt M
    Eur J Haematol; 2010 Oct; 85(4):368-9. PubMed ID: 20561035
    [No Abstract]   [Full Text] [Related]  

  • 12. Do cytogenetic abnormalities precede morphologic abnormalities in a developing malignant condition?
    Northup JK; Gadre SA; Ge Y; Lockhart LH; Velagaleti GV
    Eur J Haematol; 2007 Feb; 78(2):152-6. PubMed ID: 17313561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Femoral osteolytic lesions with soft tissue tumors and hypercalcemia as presentation form of a B-cell lymphoma].
    Hernández Hernández JL; Olmos Martínez JM; Figols Ladrón de Guevara J; Riancho Moral JA; González Macías J
    An Med Interna; 2000 May; 17(5):264-6. PubMed ID: 10859829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary non-Hodgkin's lymphoma of the mandible. Report of a case.
    Longo F; De Maria G; Esposito P; Califano L
    Int J Oral Maxillofac Surg; 2004 Dec; 33(8):801-3. PubMed ID: 15556331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection combined with CHOP chemotherapy plus rituximab for a patient with advanced mesenteric diffuse large B cell lymphoma.
    Yamaguchi T; Takahashi H; Kagawa R; Takeda R; Sakata S; Nishizaki D; Takamatsu T; Iwasa Y
    Hepatogastroenterology; 2008; 55(84):891-4. PubMed ID: 18705290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-Hodgkin malignant lymphoma of rib origin: report of a case].
    Kambayashi T; Ono N; Terada Y
    Kyobu Geka; 2005 Dec; 58(13):1177-80. PubMed ID: 16359022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extranodal non-Hodgkin's lymphoma associated with systemic bone metastasis and secondary myelofibrosis].
    Kasahara K; Takahashi T; Oka T; Yamamoto M; Sirata T; Idogawa M; Naeshiro M; Hayashi T; Adachi M; Hinoda Y; Imai K
    Rinsho Ketsueki; 1998 Dec; 39(12):1180-4. PubMed ID: 10028851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Mey UJ; Orlopp KS; Flieger D; Strehl JW; Ho AD; Hensel M; Bopp C; Gorschlüter M; Wilhelm M; Birkmann J; Kaiser U; Neubauer A; Florschütz A; Rabe C; Hahn C; Glasmacher AG; Schmidt-Wolf IG
    Cancer Invest; 2006 Oct; 24(6):593-600. PubMed ID: 16982464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adult T-cell leukemia/lymphoma of bone with multiple pathological fractures].
    Yamamoto Y; Ishii K; Nomura S; Fukuhara S
    Rinsho Ketsueki; 2004 Mar; 45(3):247-9. PubMed ID: 15103941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression during chemotherapy of lytic bone lesions in a patient with type B malignant non-Hodgkin's lymphoma].
    Pertuiset E; Leblond-Missenard V; Raphaël M; Gabarre J; Binet JL; Dombret MC
    Rev Rhum Mal Osteoartic; 1989 Dec; 56(12):883-5. PubMed ID: 2617099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.